73908-01-7 Usage
Molecular Weight
202.26 g/mol
Structure
A complex ring structure consisting of a pyrazolo[4,3-g]quinazoline core with two dione groups at positions 5 and 7.
Biological Activity
Has shown potential for anti-cancer and anti-inflammatory properties.
Classification
Heterocyclic compound belonging to the group of quinazoline derivatives.
Medicinal Chemistry
Interesting target for further research and development as a pharmaceutical drug.
Unique Features
Unique structure and potential biological activity make it a promising candidate for the development of new drugs.
Check Digit Verification of cas no
The CAS Registry Mumber 73908-01-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,9,0 and 8 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 73908-01:
(7*7)+(6*3)+(5*9)+(4*0)+(3*8)+(2*0)+(1*1)=137
137 % 10 = 7
So 73908-01-7 is a valid CAS Registry Number.
73908-01-7Relevant academic research and scientific papers
Synthesis of prox-Benzoisoallopurinol
Foster, Robert H.,Leonard, Nelson J.
, p. 3072 - 3077 (2007/10/02)
Pyrazoloquinazolin-9-one (prox-benzoisoallopurinol, 1), an extented analogue of 7-hydroxypyrazolopyrimidine (isoallopurinol, 2) and a potential dimensional probe for substrates of xanthine oxidase, has been synthesized by two independent routes.The title compound, prepared by elaboration of either a suitably substituted indazole or a quinazolinone, was found to be an active substrate for and an alternative-substrate inhibitor of xanthine oxidase.The product of enzymatic oxidation of prox-benzoisoallopurinol has been identified as the corresponding prox-benzoisoalloxanthine.
